Immunoglobulin heavy variable (II)-30-1 (pseudogene) (IGHV(II)-30-1)

The entry "immunoglobulin heavy variable (II)-30-1" (IGHVII-30-1) refers to a **pseudogene** variant of the immunoglobulin heavy variable (IGHV) gene family, which encodes the variable region of immunoglobulin heavy chains. Immunoglobulin heavy variable genes are a key part of the adaptive immune system, allowing B cells to generate diverse antibodies through V(D)J recombination. “(II)-30-1” and related aliases likely represent a nonfunctional or pseudogene variant, not an expressed gene product or functional receptor. No evidence supports this gene as a therapeutic target, nor are there specific drugs, diseases, or biomarkers associated with it as a target. The IGHV gene family is responsible for the diversity of the antibody variable region, crucial for antigen specificity in the immune response. IGHV3-30, IGHV4-30, and related variants are well-characterized, but "IGHVII-30-1" is not a standard or widely accepted nomenclature, and "II" may refer to a subgroup, but more likely identifies a pseudogene or poorly characterized allele. Listings at gene/inventory databases and product catalogs group this variant as a pseudogene; it is not listed among functional targets for therapy or drug development. No direct associations with disease mechanisms, drug interactions, or biomarker usage are described in scientific or clinical literature reviewed. This entry is not a well-established therapeutic target and is best classified as a pseudogene or nonfunctional gene segment. No drugs, mechanisms, or safety concerns are established for this entry. If seeking data on a functional antibody V-region, refer to canonical IGHV genes such as IGHV3-30 or IGHV4-30.

Other names

IGHVII-30-1IGHV(II)-30-14-30.1PIGHVII301